Radiotherapy for urinary bladder pheochromocytoma with invasion of the prostate: A case report and literature review.

Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med (2002) 6.94

Extra-adrenal pheochromocytoma. J Urol (1992) 3.28

Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab (2007) 3.25

Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev (2003) 2.96

Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer (2004) 2.20

Malignant pheochromocytoma of the urinary bladder: challenges in diagnosis and management. Isr Med Assoc J (2011) 1.67

Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev (2009) 1.63

Detecting pheochromocytoma: defining the most sensitive test. Ann Surg (2006) 1.47

Pheochromocytoma of the urinary bladder without typical symptoms. Int J Urol (2003) 1.46

Phaeochromocytoma of the urinary bladder. Singapore Med J (2005) 1.44

Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. Eur J Radiol (2008) 1.21

Pheochromocytoma of the urinary bladder. APMIS (2002) 1.11

Bladder paraganglioma in adults: MR appearance in four patients. Eur J Radiol (2010) 1.05

Radiation treatment of recurrent pheochromocytoma of the bladder: case report and review of literature. Am J Clin Oncol (2002) 0.96

Radiation therapy of metastatic pheochromocytoma: case report and review of the literature. Am J Clin Oncol (1996) 0.95

Transarterial liver-directed therapies of neuroendocrine hepatic metastases. Semin Oncol (2010) 0.94

Pheochromocytoma of urinary bladder. Indian J Nephrol (2011) 0.93

Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging. Oncol Rep (2002) 0.89

Malignant pheochromocytoma, still a therapeutic challenge. Am J Hypertens (1997) 0.87

Diagnostic management of benign and malignant pheochromocytoma. Exp Clin Endocrinol Diabetes (2007) 0.83

Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas. J Intern Med (2001) 0.82

A 3-year follow-up study of β-cell function in patients with early-onset type 2 diabetes. Exp Ther Med (2016) 0.75